PRNewsWire - Health

CStone Presents the Latest Preclinical Findings of CS2009 (PD-1/VEGF/CTLA-4 trispecific antibody) at 2025 AACR
Innovent Announces Oral Presentation of Full Phase 2 Clinical Data for Efdamrofusp Alfa (IBI302), First-in-class anti-VEGF/complement Bispecific Fusion Protein at ARVO 2025
CANCER TREATMENT CENTER REMINDS WOMEN TO INCLUDE HEALTH SCREENINGS ON THEIR SPRING TO-DO LISTS
Madhappy Hosts One-Night-Only Fundraiser at Pacific Park in Support of 'Mental Health Awareness Month'